(34.200.243.114)
Users online: 2881    [ij] [ij] [ij] 
Email id
 

Research Journal of Pharmacy and Technology
Year : 2019, Volume : 12, Issue : 11
First page : ( 5413) Last page : ( 5423)
Print ISSN : 0974-3618. Online ISSN : 0974-360X.
Article DOI : 10.5958/0974-360X.2019.00939.9

Design and In-Silico ADMET Analysis of new Benzopyrane-derived Pim-1 Inhibitors

Khdar Zein Alabdeen1, Sliman Faten2,*, Kousara Mohammad3

1Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Tishreen University, Lattakia, Syria. zen.khdar@hotmail.com

2Department of Pharmaceutical Chemistry, Faculty of pharmacy, Tartous University, Syria

3Department of Pharmaceutical Chemistry, Faculty of pharmacy, Tishreen University, Lattakia, Syria, mohammadkousara@tishreen.edu.sy

*Corresponding Author E-mail: Fatensliman@tartous-univ.edu.sy

Online published on 9 April, 2020.

Abstract

Pim-1 (Proviral Insertion site of Molony Murine Leukemia virus) kinases is an oncogene which is known to be over expressed and dysregulated in hematological and solid tumors suggesting that inhibition of Pim-1 signaling could provide patients with therapeutic benefits. Herein, we describe our effort towards this goal by using molecular modeling Methods. We have designed (64) compounds derived from 2-(3, 4-dihydro-1-Benzopyran) acetic acid (compound 5). The docking study with Pim-1 crystal structure was performed by using CDocker and Ligand fit docking Methods. Then hits were filtered based on In-silico ADMET properties. This study led to conclude that compounds Benz30 and Benz53 could be promise Pim-1 inhibitors with preferred ADMET properties.

Top

Keywords

Pim-1, hinge region, tumors, benzopyran, CDocker, Ligand fit, ADMET.

Top

  
║ Site map ║ Privacy Policy ║ Copyright ║ Terms & Conditions ║ Page Rank Tool
434,940,017 visitor(s) since 30th May, 2005.
All rights reserved. Site designed and maintained by DIVA ENTERPRISES PVT. LTD..
Note: Please use Internet Explorer (6.0 or above). Some functionalities may not work in other browsers.